| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | $65.32M | $67.64M | $79.20M | $86.16M | $97.07M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $106.74M | $131.48M | $163.52M | $164.52M | $174.11M |
| SG&A | $43.93M | $57.85M | $52.89M | $45.48M | $32.54M |
| Operating Income | -$85.35M | -$121.69M | -$137.21M | -$123.84M | -$109.57M |
| Interest Expense | – | – | $5.15M | $0.00 | $0.00 |
| Tax Expense | -$1.66M | -$1.74M | $2.82M | -$433.00K | -$28.58M |
| Net Income | -$81.89M | -$116.05M | -$133.82M | -$121.75M | -$79.00M |
| EPS (basic) | -3.8400 | -5.4800 | -6.3800 | -5.9100 | -3.9200 |
| EPS (diluted) | -3.8400 | -5.4800 | -6.3800 | -5.9100 | -3.9200 |
| Shares (diluted) | $21.34K | $21.16K | $20.97K | $20.60K | $20.17M |